Leef Brands AI Stock Analysis
Want to see TSE:LEEF full AI Analyst Report?
Leef Brands (LEEF) AI Stock Analysis
Leef Brands
(CNQX:LEEF)
The overall score of 45 reflects a high-risk, early-stage turnaround situation. The company's extremely weak financial performance and bearish technicals are significant drags. However, these are partially offset by a credible strategic plan outlined in the earnings call, which includes a strengthened balance sheet, operational milestones, and a clear path to improved margins from vertical integration. The primary risk remains the company's ability to execute this plan and achieve sustainable profitability before its cash reserves are depleted.
Leef Brands (LEEF) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 31.57M
- Dividend Yield
- ―
- Average Volume (3M)
- 91.21K
- Price to Earnings (P/E)
- -1.7
- Beta (1Y)
- 0.00
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- Canada
- Employees
- 81
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
Leef Brands Business Overview & Revenue Model
Company Description
Leef Brands Inc. operates as a U.S.-based manufacturer of branded cannabis products. The company's operations are divided into two main divisions: Wholesale Concentrates and Retail. Its Wholesale Concentrates segment manages the complete production c...
How the Company Makes Money
Leef Brands primarily makes money by selling cannabis products into legal state markets through (1) branded product sales and (2) contract/white-label manufacturing and product supply for third parties. Revenue is generated when products are sold to...
Leef Brands Earnings Call Summary
The call portrayed a company in transition: Q2 showed temporary softness with a 16% revenue decline, negative adjusted EBITDA for the quarter and volume pullbacks due to running purchased biomass. Offsetting those near-term headwinds are strong strategic and operational developments — an oversubscribed capital raise (~$14.2M YTD), completion of the largest harvest with exceptionally high-quality oil (95% THC, passed CAT4), acquisition of HIMALAYA (added ~$1M revenue), materially improved gross profit (+62% YoY) and margin expansion (33% vs 17% prior year), a growing acreage footprint targeting 180 acres in 2027, new processing capacity, and active regulatory and customer engagement positioning the company for interstate and export opportunities. Overall, management presented these negatives as temporary and solvable via vertical integration and recent investments.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
The company guided that its Q2 softness was temporary and tied to running third‑party biomass, with revenue down 16% to $7.3M, unit volumes down ~20% partially offset by a ~5% ASP improvement, and adjusted EBITDA of negative $631k (first half adjusted EBITDA still +$1.7M vs -$2.1M YoY), while gross profit rose 62% to $2.4M and gross margin nearly doubled to 33% from 17% as hydrocarbon products became the largest revenue category; operationally Leef completed an oversubscribed $9.3M financing, raised roughly $9M in H1 plus $5.2M in July (≈$14.2M YTD) to buy a processing facility, acquired Himalaya (≈$1M contributed in the partial quarter), filed DEA registration applications, finished its largest harvest with the first several hundred liters in July testing ~95% THC / ~99% total cannabinoids and passing CA CAT4 screens, and expects acreage to reach ~122 acres this fall (an 88% YoY increase) en route to operating the full 180‑acre permit in 2027 (plus contracted/partnered 21‑acre blocks), inventory grew to $7.1M (WIP $4.2M), cash was $5M (from $2.2M), working capital turned to a surplus of $8.7M, and management reiterated that running its own biomass historically drives gross margins toward ~50% (vs ~33% on bought material), with margin and distillate volume recovery expected in late Q3 and into Q4 and longer‑term cost targets like distillate < $0.50/gram (vs CA sell price ~$1/g and potential out‑of‑state prices of $3.50–$12/g) implying very high incremental margins.
Leef Brands Financial Statement Overview
Summary
Financial health is critically weak. The company has persistent net losses, negative stockholders' equity, and negative operating cash flow. While gross margin improved to 31.5% and total debt was reduced, the core operations are not self-sustaining, posing a high risk.
Income Statement
18Very NegativeBalance Sheet
8Very NegativeCash Flow
22Negative| Breakdown | TTM | Dec 2025 | Dec 2025 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.77M | 30.75M | 34.79M | 28.50M | 30.61M | 27.00M |
| Gross Profit | 12.62M | 7.62M | 10.48M | 8.94M | 10.02M | 9.55M |
| EBITDA | -11.08M | -17.39M | -10.44M | -14.26M | -33.41M | -18.89M |
| Net Income | -18.32M | -17.63M | -17.63M | -24.62M | -34.97M | -28.92M |
Balance Sheet | ||||||
| Total Assets | 41.85M | 41.27M | 36.40M | 42.98M | 44.00M | 61.93M |
| Cash, Cash Equivalents and Short-Term Investments | 5.76M | 887.89K | 2.19M | 2.73M | 6.41M | 3.31M |
| Total Debt | 12.31M | 24.14M | 12.60M | 23.15M | 20.38M | 10.91M |
| Total Liabilities | 47.60M | 54.35M | 44.67M | 55.41M | 43.15M | 34.19M |
| Stockholders Equity | -5.75M | -13.08M | -8.27M | -12.43M | -2.80M | 23.94M |
Cash Flow | ||||||
| Free Cash Flow | -122.02K | -7.43M | -1.49M | -7.32M | -7.42M | -6.44M |
| Operating Cash Flow | 1.50M | -4.01M | -336.89K | -1.05M | 187.82K | -6.32M |
| Investing Cash Flow | -1.08M | -3.01M | -749.22K | -6.27M | -7.28M | 2.23M |
| Financing Cash Flow | 4.01M | 4.76M | 545.20K | 3.63M | 10.38M | 49.69K |
Leef Brands Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:LEEF, the sentiment is Negative. The current price of 0.22 is above the 20-day moving average (MA) of 0.22, below the 50-day MA of 0.24, and below the 200-day MA of 0.23, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 47.02 is Neutral, neither overbought nor oversold. The STOCH value of 39.39 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:LEEF.
Leef Brands Risk Analysis
Leef Brands disclosed 61 risk factors in its most recent earnings report. Leef Brands reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksLeef Brands Peers Comparison
Overall Rating
TSE:LEEF45Neutral
TSE:JUSH43Neutral
TSE:CWEB42Neutral
TSE:AYR.A40.1Neutral
TSE:PLTH39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 45Neutral | CAD 67.22M | -1.73 | 206.83% | ― | ― | ― | |
| 43Neutral | CAD 109.84M | -1.40 | 40.14% | ― | 5.37% | 17.78% | |
| 42Neutral | CAD 65.11M | -0.87 | -139.31% | ― | -9.90% | -35.35% | |
| 40Neutral | CAD 18.10M | -0.03 | -74.75% | ― | ― | ― | |
| 39Underperform | CAD 38.56M | -1.13 | -59.17% | ― | -15.64% | 71.65% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:LEEF | Leef Brands Inc | 0.22 | -0.02 | -10.20% | |
| TSE:JUSH | Jushi Holdings Inc | 0.55 | 0.02 | 3.77% | |
| TSE:CWEB | Charlotte's Web Holdings (OTC) | 0.24 | 0.10 | 71.43% | |
| TSE:AYR.A | Ayr Wellness Inc. | 0.15 | 0.00 | 0.00% | |
| TSE:PLTH | Planet 13 Holdings, Inc. | 0.12 | -0.10 | -46.51% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 31, 2026
